87 related articles for article (PubMed ID: 21614012)
1. The role of Jak3 signaling in IL-17 expression in malignant cutaneous T-cell lymphoma.
Kwatra SG
J Invest Dermatol; 2011 Sep; 131(9):1954-5; author reply 1955-6. PubMed ID: 21614012
[No Abstract] [Full Text] [Related]
2. Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.
Krejsgaard T; Ralfkiaer U; Clasen-Linde E; Eriksen KW; Kopp KL; Bonefeld CM; Geisler C; Dabelsteen S; Wasik MA; Ralfkiaer E; Woetmann A; Odum N
J Invest Dermatol; 2011 Jun; 131(6):1331-8. PubMed ID: 21346774
[TBL] [Abstract][Full Text] [Related]
3. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
Marzec M; Halasa K; Kasprzycka M; Wysocka M; Liu X; Tobias JW; Baldwin D; Zhang Q; Odum N; Rook AH; Wasik MA
Cancer Res; 2008 Feb; 68(4):1083-91. PubMed ID: 18281483
[TBL] [Abstract][Full Text] [Related]
5. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma.
Fanok MH; Sun A; Fogli LK; Narendran V; Eckstein M; Kannan K; Dolgalev I; Lazaris C; Heguy A; Laird ME; Sundrud MS; Liu C; Kutok J; Lacruz RS; Latkowski JA; Aifantis I; Ødum N; Hymes KB; Goel S; Koralov SB
J Invest Dermatol; 2018 May; 138(5):1116-1125. PubMed ID: 29128259
[TBL] [Abstract][Full Text] [Related]
6. IL-13 Signaling in CD30
Wen Y; Sun J; Yi S; Gao Y; Kouttab N; Morgan J; Wang Y; Kadin ME
J Invest Dermatol; 2021 May; 141(5):1360-1363.e3. PubMed ID: 33049271
[No Abstract] [Full Text] [Related]
7. Malignant T cells activate endothelial cells via IL-17 F.
Lauenborg B; Litvinov IV; Zhou Y; Willerslev-Olsen A; Bonefeld CM; Nastasi C; Fredholm S; Lindahl LM; Sasseville D; Geisler C; Wasik MM; Krejsgaard T; Gjerdrum LMR; Iversen L; Odum N; Woetmann A
Blood Cancer J; 2017 Jul; 7(7):e586. PubMed ID: 28731459
[No Abstract] [Full Text] [Related]
8. Serum interleukin-27 levels in patients with cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Shibata S; Ohmatsu H; Fujita H; Tamaki K
Clin Exp Dermatol; 2010 Jun; 35(4):e143-4. PubMed ID: 19874357
[No Abstract] [Full Text] [Related]
9. Interleukin-17 expression in neutrophils and Th17 cells in cutaneous T-cell lymphoma associated with neutrophilic infiltrate of the skin.
Fontao L; Brembilla NC; Masouyé I; Kaya G; Prins C; Dupin N; Saurat JH; Chizzolini C; Piguet V
Br J Dermatol; 2012 Mar; 166(3):687-9. PubMed ID: 21936854
[No Abstract] [Full Text] [Related]
10. Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients.
Wismer JM; McKenzie RC; Sauder DN
Lymphokine Cytokine Res; 1994 Feb; 13(1):21-7. PubMed ID: 8186321
[TBL] [Abstract][Full Text] [Related]
11. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.
Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Lovato P; Labuda T; Eriksen KW; Zhang Q; Becker JC; Ødum N
Leukemia; 2006 Oct; 20(10):1759-66. PubMed ID: 16932349
[TBL] [Abstract][Full Text] [Related]
12. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
Zhang Q; Raghunath PN; Vonderheid E; Odum N; Wasik MA
Am J Pathol; 2000 Oct; 157(4):1137-46. PubMed ID: 11021818
[TBL] [Abstract][Full Text] [Related]
13. Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma.
Han Y; Amin HM; Frantz C; Franko B; Lee J; Lin Q; Lai R
Leukemia; 2006 Sep; 20(9):1602-9. PubMed ID: 16871283
[TBL] [Abstract][Full Text] [Related]
14. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of interleukin-18 are increased in patients with cutaneous T-cell lymphoma and cutaneous natural killer-cell lymphoma.
Amo Y; Ohta Y; Hamada Y; Katsuoka K
Br J Dermatol; 2001 Oct; 145(4):674-6. PubMed ID: 11703305
[No Abstract] [Full Text] [Related]
16. Role of cytokines and Jak3/Stat3 signaling in the 1,2-dimethylhydrazine dihydrochloride-induced rat model of colon carcinogenesis: early target in the anticancer strategy.
Saini MK; Vaish V; Sanyal SN
Eur J Cancer Prev; 2013 May; 22(3):215-28. PubMed ID: 23514809
[TBL] [Abstract][Full Text] [Related]
17. A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection.
Walsh PT; Benoit BM; Wysocka M; Dalton NM; Turka LA; Rook AH
J Invest Dermatol; 2006 Mar; 126(3):690-2. PubMed ID: 16410788
[No Abstract] [Full Text] [Related]
18. Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.
Lauenborg B; Christensen L; Ralfkiaer U; Kopp KL; Jønson L; Dabelsteen S; Bonefeld CM; Geisler C; Gjerdrum LM; Zhang Q; Wasik MA; Ralfkiaer E; Ødum N; Woetmann A
Oncotarget; 2015 Jun; 6(17):15235-49. PubMed ID: 25915535
[TBL] [Abstract][Full Text] [Related]
19. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
[TBL] [Abstract][Full Text] [Related]
20. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Sim SH; Kim S; Kim TM; Jeon YK; Nam SJ; Ahn YO; Keam B; Park HH; Kim DW; Kim CW; Heo DS
Am J Pathol; 2017 May; 187(5):980-986. PubMed ID: 28284718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
